- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02776085
Bedside Ultrasound to Measure Optic Nerve Sheath Diameter in Pediatric CSF Shunts
April 20, 2022 updated by: Wake Forest University Health Sciences
Using Bedside Ultrasound to Measure the Optic Nerve Sheath Diameter in the Evaluation of Pediatric Patients With CSF Shunts
Bedside ultrasound in the emergency department is useful for quick assessments of patients.
One growing use is to measure the optic nerve sheath diameter of patients for whom increased pressure in the head is a concern.
This study will look at the optic nerve sheath diameters of a specific population of pediatric patients with shunts that drain extra fluid from their heads.
Study Overview
Status
Completed
Conditions
Detailed Description
The particular interest of this study is the use of ultrasound to evaluate a child's optic nerve sheath diameter (ONSD), or the size of the covering around the nerve behind the eye.
This covering expands when there is a higher than normal pressure inside the head.
The group of interest on which this study focuses is the children with cerebrospinal shunts that drain extra fluid from their heads to other parts of the body (abdomen, heart, lungs) because the brain cannot drain all of the fluid like normal.
When these shunts malfunction or fail, this can cause a backup of fluid in the brain, and raise the intracranial pressure (ICP) inside the skull.
Depending on the degree of pressure buildup, this can be a surgical emergency due to pressure on the brain.
Currently, computed tomography (CT) scans or magnetic resonance imaging (MRI) scans are used to diagnose the condition, but a quick screening tool, such as use of ultrasound to screen for elevated ICP in the emergency department, would be of great benefit to the patients to expedite care.
Previous studies have explored the use of bedside ultrasound to evaluate the optic nerve sheath diameter in children with shunts.
However, to date, there have been no reported prospective observational studies that compared before and after ultrasound measurements of the ONSD in patients in whom shunt failure is diagnosed and treated.
Of note, this study is observational and the measurements taken with the ultrasound machine will not be used for clinical decision making.
The measurements in this study will have no clinical impact on patient care.
The use of ultrasound to measure the ONSD is an already accepted application of ultrasound.
Study Type
Observational
Enrollment (Actual)
64
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28203
- Carolinas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 17 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pediatric patients with cerebrospinal fluid shunts who are evaluated in the emergency department for any reason, or are admitted to the hospital through the neurosurgery clinic.
Description
Inclusion Criteria:
- Children and adolescents, ages 6 months through 17 years who have a shunt and who present to the children's emergency department for evaluation and treatment.
- Children and adolescents, ages 6 months through 17 years who have a shunt and are directly admitted to the inpatient children's hospital from an outside facility.
Exclusion Criteria:
- Patients for whom the parents or guardians do not agree to participate in the study.
- Patients with any acute trauma to the eyes, face, or head.
- Severe anaphylactic allergy to ultrasound gel or Tegaderm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Asymptomatic
Group of patients with CSF shunts who are evaluated for a reason other than concern for shunt failure.
The optic nerve sheath diameter of these patients will be used as baseline measurements for children with CSF shunts.
|
Symptomatic, Not Admitted
Group of patients with CSF shunts who are evaluated for concerns of shunt malfunction or failure, but either have shunt failure ruled out, or are felt to be safe for discharge to home.
They are not admitted to the hospital.
The optic nerve sheath diameter of these patients will be measured once in the emergency department.
|
Symptomatic, Admitted
Group of patients with CSF shunts who are evaluated for concerns of shunt malfunction or failure, and then are admitted to the hospital secondary to these concerns.
The optic nerve sheath diameter of these patients will be measured once in the emergency department or as close to admission as possible, and then measured again while they are still inpatient, but after they have an intervention performed (medical or surgical) to relieve their shunt malfunction or failure.
These patients will have their initial optic nerve sheath diameters compared to the other two populations, but they will also have their initial and final optic nerve sheath diameters compared to each other.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare the initial and final optic nerve sheath diameters measured by ultrasound in patients who are admitted for shunt failure
Time Frame: 3 days
|
Patients will have their ONSD measured by ultrasound in the emergency department or immediately after admission.
After they either receive antibiotics or shunt revision surgery, and are no longer symptomatic from shunt failure, their ONSD will be measured again and compared to the initial measurement.
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare the optic nerve sheath diameter measurements of asymptomatic patients vs symptomatic patients who are not diagnosed with shunt failure vs those are diagnosed with shunt failure and admitted.
Time Frame: 6 months
|
The ONSD will be measured for all pediatric patients with CSF shunts who come to the emergency department, and then the average measurements of each group will be compared to the other two groups to evaluate if there are significant differences in the measurements.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physician Funduscopy Accuracy
Time Frame: 6 months
|
The results of physician funduscopy of symptomatic patients will be compared to the imaging done for children to evaluate if physicians can visualize signs of increased intracranial pressure on funduscopic exam.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christyn Magill, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
January 1, 2018
Study Completion (Actual)
January 1, 2019
Study Registration Dates
First Submitted
May 16, 2016
First Submitted That Met QC Criteria
May 16, 2016
First Posted (Estimate)
May 18, 2016
Study Record Updates
Last Update Posted (Actual)
April 28, 2022
Last Update Submitted That Met QC Criteria
April 20, 2022
Last Verified
January 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- ONSD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebrospinal Fluid Shunts
-
Basim AsmarForest LaboratoriesUnknownVentriculoperitoneal Shunt | Cerebrospinal Fluid ShuntsUnited States
-
Assiut UniversityRecruiting
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCerebrospinal FluidBelgium
-
The Cleveland ClinicCompletedCerebrospinal Fluid Drainage Catheter
-
First People's Hospital of ChenzhouNot yet recruiting
-
Yi Feng, MDUnknownAged | Flurbiprofen Axetil | Anesthesia, Spinal | Cerebrospinal FluidChina
-
Kuros Biosurgery AGCompletedCerebrospinal Fluid LeakageGermany, Hungary
-
TakedaCompletedCerebrospinal Fluid LeaksAustria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden
-
University of ZurichCompletedCerebrospinal Fluid LeakageSwitzerland
-
University of North Carolina, Chapel HillUNC Medical AlumniCompletedCerebrospinal Fluid DrainageUnited States